Manufacturer record
Sanctus Global Formulations Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Sanctus Global Formulations Limited (Himachal Pradesh) were declared Not of Standard Quality between December 2023 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: SG25068, Metoprolol Tartrate Tablets IP 50mg (Metoder 50) (exp May 2027). DTL Konni (state lab) found it not of standard quality: Sample fails the test ' Dissolution' mentioned in the Laboratory Protocol as per IP. Listed in the February 2026 alert.
Records by type
4 records linked to Sanctus Global Formulations Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Metoprolol Tartrate Tablets IP 50mg (Metoder 50) | Batch SG25068Mfg Jun 2025 · Exp May 2027 | Sample fails the test ' Dissolution' mentioned in the Laboratory Protocol as per IP.Dissolution | DTL KonniState lab | Feb 2026 |
| Pantoprazole Gastro Reistant and Dompendone Prolonged Release Capsule IP | Batch 2307045Mfg Jul 2023 · Exp Jul 2025 | DissolutionDissolution | DTL, JaipurState lab | Aug 2025 |
| Clopidogrel and Aspirin Tablets IP (AclizacAS 75) | Batch 2411039Mfg Nov 2024 · Exp Oct 2026 | The sample does not conform to the IP with respect to Assay of Aspirin & Free Salicylic AcidAssay | DTL,Jaipur (StateState lab | May 2025 |
| Glimepiride Tablets I.P. (Glimicut-1) | Batch SG22022Mfg Mar 2022 · Exp Feb 2024 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.